AP1246A - Substituted pyrazoles as p38 Kinase inhibitors. - Google Patents

Substituted pyrazoles as p38 Kinase inhibitors.

Info

Publication number: AP1246A
Authority: AP; ARIPO
Prior art keywords: kinase inhibitors; substituted pyrazoles; pyrazoles; substituted; class
Prior art date: 1997-05-22

Application number

APAP/P/1999/001715A

Other languages

English (en)

Other versions

AP9901715A0 (en

Inventor

Ashok Anantanarayan

Michael Clare

Paul W Collins

Joyce Zuowu Crich

Rajesh Devraj

Daniel L Flynn

Lifeng Geng

Gunnar J Hanson

Francis J Koszyk

Shuyuan Liao

Richard A Partis

Shashidhar N Rao

Shaun Raj Selness

Michael J South

Michael A Stealey

Richard M Weier

Xiangdong Xu

Original Assignee

Searle & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-22

Filing date

1998-05-22

Publication date

2004-02-07

1998-05-22 Application filed by Searle & Co filed Critical Searle & Co

1999-12-31 Publication of AP9901715A0 publication Critical patent/AP9901715A0/xx

2004-02-07 Application granted granted Critical

2004-02-07 Publication of AP1246A publication Critical patent/AP1246A/en

Links

150000003217 pyrazoles Chemical class 0.000 title abstract 2
229940043355 kinase inhibitor Drugs 0.000 title 1
239000003757 phosphotransferase inhibitor Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

APAP/P/1999/001715A 1997-05-22 1998-05-22 Substituted pyrazoles as p38 Kinase inhibitors. AP1246A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4757097P	1997-05-22	1997-05-22
PCT/US1998/010436 WO1998052940A1 (en)	1997-05-22	1998-05-22	SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS

Publications (2)

Publication Number	Publication Date
AP9901715A0 AP9901715A0 (en)	1999-12-31
AP1246A true AP1246A (en)	2004-02-07

Family

ID=21949743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/1999/001715A AP1246A (en)	1997-05-22	1998-05-22	Substituted pyrazoles as p38 Kinase inhibitors.

Country Status (24)

Country	Link
EP (1)	EP1000055A1 (is)
JP (1)	JP2002508754A (is)
KR (1)	KR20010012854A (is)
CN (1)	CN1264377A (is)
AP (1)	AP1246A (is)
AU (1)	AU754830C (is)
BG (1)	BG64313B1 (is)
BR (1)	BR9809147A (is)
CA (1)	CA2291115A1 (is)
EA (1)	EA003925B1 (is)
EE (1)	EE9900527A (is)
GE (1)	GEP20033053B (is)
HU (1)	HUP0001880A3 (is)
ID (1)	ID22982A (is)
IL (1)	IL132991A (is)
IS (1)	IS5257A (is)
NO (1)	NO995695L (is)
NZ (1)	NZ501112A (is)
OA (1)	OA12981A (is)
PL (1)	PL337020A1 (is)
SK (1)	SK157899A3 (is)
TR (1)	TR200000235T2 (is)
WO (1)	WO1998052940A1 (is)
ZA (1)	ZA984358B (is)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW289752B (is) *	1994-03-11	1996-11-01	Ciba Geigy Ag
US5559137A (en) *	1994-05-16	1996-09-24	Smithkline Beecham Corp.	Compounds
US6979686B1 (en)	2001-12-07	2005-12-27	Pharmacia Corporation	Substituted pyrazoles as p38 kinase inhibitors
JP2002502380A (ja)	1997-05-22	2002-01-22	ジー．ディー．サールアンドカンパニー	ｐ３８キナーゼ阻害剤としてのピラゾール誘導体
US6514977B1 (en)	1997-05-22	2003-02-04	G.D. Searle & Company	Substituted pyrazoles as p38 kinase inhibitors
WO1998056377A1 (en)	1997-06-13	1998-12-17	Smithkline Beecham Corporation	Novel pyrazole and pyrazoline substituted compounds
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
US6184226B1 (en) *	1998-08-28	2001-02-06	Scios Inc.	Quinazoline derivatives as inhibitors of P-38 α
CA2346665A1 (en)	1998-10-07	2000-04-13	Smithkline Beecham Corporation	Novel treatment for stroke management
US6548503B1 (en)	1998-11-04	2003-04-15	Smithkline Beecham Corporation	Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
ES2188280T3 (es)	1998-12-16	2003-06-16	Aventis Pharma Ltd	Acetales heteroaril-ciclicos.
US6191147B1 (en) *	1998-12-24	2001-02-20	Ppd Discovery, Inc.	Pyrazole compounds and uses thereof
ES2244231T3 (es) *	1998-12-25	2005-12-01	Teikoku Hormone Mfg. Co., Ltd.	Derivados de aminopirazol.
ES2345921T3 (es)	1999-03-26	2010-10-06	Euro-Celtique S.A.	Pirazoles, imidazoles, oxazoles, tiazoles y pirroles sustituidos con arilo y su uso.
AU766079B2 (en)	1999-06-03	2003-10-09	Teikoku Hormone Mfg. Co., Ltd.	Substituted pyrazole compounds
US7122666B2 (en)	1999-07-21	2006-10-17	Sankyo Company, Limited	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
HK1045507A1 (zh) *	1999-08-12	2002-11-29	Vertex Pharmaceuticals Incorporated	C-jun n-末端激酶(jnk)及其他蛋白质激酶的抑制物
AU7922100A (en) *	1999-10-25	2001-05-08	Basf Aktiengesellschaft	Agrochemical compositions containing pyrazoles as the active agents and use of said compositions as plant protection agents with a fungicidal action
DE19952147A1 (de)	1999-10-29	2001-05-03	Boehringer Ingelheim Pharma	Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JP2003528043A (ja)	1999-11-23	2003-09-24	スミスクライン・ビーチャム・コーポレイション	ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４‐ジヒドロ−（１Ｈ）キナゾリン−２−オン化合物
US7053099B1 (en)	1999-11-23	2006-05-30	Smithkline Beecham Corporation	3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
WO2001038314A1 (en)	1999-11-23	2001-05-31	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
PT1309592E (pt)	2000-08-14	2006-07-31	Ortho Mcneil Pharm Inc	Pirazoles substituidos
EP1364949A4 (en) *	2001-02-02	2005-11-23	Takeda Pharmaceutical	JNK INHIBITOR
GB0102687D0 (en)	2001-02-02	2001-03-21	Pharmacia & Upjohn Spa	Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
JP4310109B2 (ja)	2001-04-26	2009-08-05	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピラゾリル基を置換基として有する含窒素縮合環化合物およびその医薬組成物
HRP20030961B1 (en)	2001-05-24	2012-01-31	Eli Lilly And Company	Novel pyrrole derivatives as pharmaceutical agents
RU2277534C2 (ru) *	2001-09-25	2006-06-10	Фармация Корпорейшн	Способ получения замещенных пиразолов
US7057049B2 (en)	2001-09-25	2006-06-06	Pharmacia Corporation	Process for making substituted pyrazoles
MXPA04002855A (es)	2001-09-25	2004-07-05	Pharmacia Corp	Proceso para producir pirazoles sustituidos.
WO2003104223A1 (en) *	2002-06-05	2003-12-18	Pharmacia Corporation	Pyrazole-derivatives as p38 kinase inhibitors
WO2004004725A2 (en)	2002-07-09	2004-01-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
GB0215844D0 (en)	2002-07-09	2002-08-14	Novartis Ag	Organic compounds
GB0217786D0 (en) *	2002-07-31	2002-09-11	Glaxo Group Ltd	Compounds
US6649638B1 (en)	2002-08-14	2003-11-18	Ppd Discovery, Inc.	Prenylation inhibitors and methods of their synthesis and use
AU2003265395A1 (en)	2002-08-14	2004-03-03	Ppd Discovery, Inc.	Prenylation inhibitors and methods of their synthesis and use
AU2003268155A1 (en) *	2002-09-19	2004-04-08	Eli Lilly And Company	Methods of inhibiting tgf beta with substituted pyrazoles
GB0229618D0 (en)	2002-12-19	2003-01-22	Cancer Rec Tech Ltd	Pyrazole compounds
PL377848A1 (pl)	2003-02-07	2006-02-20	Daiichi Pharmaceutical Co., Ltd.	Pochodne pirazoli
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
DE602005010714D1 (de)	2004-08-12	2008-12-11	Pfizer	Der p38-map-kinase
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
ATE538118T1 (de)	2004-12-28	2012-01-15	Aska Pharm Co Ltd	Pyrimidinylisoxazolderivat
CA2643066A1 (en) *	2006-03-16	2007-09-20	Pfizer Products Inc.	Pyrazole compounds
US20090192164A1 (en)	2006-06-28	2009-07-30	Aska Pharmaceutical Co., Ltd.	Treating agent of inflammatory bowel disease
ES2396251T3 (es)	2006-06-28	2013-02-20	Aska Pharmaceutical Co., Ltd.	Derivado de piridilisoxazol
JP4588791B2 (ja)	2007-02-16	2010-12-01	あすか製薬株式会社	微粒子油性懸濁液を含む医薬組成物
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US20100144756A1 (en) *	2007-07-13	2010-06-10	Bolea Christelle	Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
EP2220048B1 (en)	2007-11-16	2017-01-25	Boehringer Ingelheim International GmbH	Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
CL2009000904A1 (es)	2008-04-21	2010-04-30	Shionogi & Co	Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende.
WO2009138386A2 (en)	2008-05-13	2009-11-19	Boehringer Ingelheim International Gmbh	Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
PL2324008T3 (pl)	2008-07-24	2012-09-28	Nerviano Medical Sciences Srl	3,4-diarylopirazole jako inhibitory kinazy białkowej
US8609690B2 (en) *	2008-08-25	2013-12-17	Boehringer Ingelheim International Gmbh	Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
JP2012506388A (ja) *	2008-10-23	2012-03-15	ロンザリミテッド	置換されたピラゾールの合成方法
MX2011005221A (es) *	2008-11-21	2011-08-03	Raqualia Pharma Inc	Nuevo derivado de la pirazol-3-carboxamida que tiene actividad de antagonista del receptor de 5-ht2b.
JP5670440B2 (ja)	2009-06-02	2015-02-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
EP2440537A1 (en)	2009-06-11	2012-04-18	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
AU2010288534A1 (en) *	2009-08-26	2012-03-15	Novartis Ag	Tetra-substituted heteroaryl compounds and their use as MDM2 and/or MDM4 modulators
AR077975A1 (es)	2009-08-28	2011-10-05	Irm Llc	Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
EP2308866A1 (de)	2009-10-09	2011-04-13	Bayer CropScience AG	Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
BR112012018358A2 (pt)	2009-12-21	2016-08-09	Bayer Cropscience Ag	tienilpiri(mi)dinilazol e seu uso para controlar fungos fitopatogênicos
CN104958294A (zh)	2010-01-27	2015-10-07	内尔维安诺医学科学有限公司	作为蛋白激酶抑制剂的3,4-二芳基吡唑的亚磺酰氨基衍生物
AR081810A1 (es)	2010-04-07	2012-10-24	Bayer Cropscience Ag	Piridinilpirazoles biciclicos
EP2582698B1 (en)	2010-06-16	2016-09-14	Vitae Pharmaceuticals, Inc.	Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
JP5938038B2 (ja)	2010-08-03	2016-06-22	ネルヴィアーノ・メディカル・サイエンシズ・ソチエタ・ア・レスポンサビリタ・リミタータ	ピラゾロフェニル−ベンゼンスルホンアミド化合物の誘導体及びその抗腫瘍薬としての使用
HUE032405T2 (en) *	2010-12-20	2017-09-28	Pfizer	New condensed pyridine compounds as casein kinase inhibitors
WO2012175513A1 (en)	2011-06-20	2012-12-27	Bayer Intellectual Property Gmbh	Thienylpyri(mi)dinylpyrazole
JP2014524438A (ja)	2011-08-17	2014-09-22	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	インデノピリジン誘導体
UA114490C2 (uk)	2011-10-06	2017-06-26	Байєр Інтеллектуал Проперті Гмбх	Гетероциклілпіри(mі)динілпіразоли як фунгіциди
JP6211522B2 (ja)	2011-10-06	2017-10-11	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	ヘテロシクリルピリ（ミ）ジニルピラゾール
DE102011115525A1 (de)	2011-10-11	2013-04-11	Boehringer Ingelheim International Gmbh	Zweiteilige Flasche mit einem darin angeordneten Trockenmittel
US11007194B2 (en)	2011-11-11	2021-05-18	Array Biopharma Inc.	Method of treating a proliferative disease
WO2013078264A1 (en)	2011-11-23	2013-05-30	Novartis Ag	Pharmaceutical formulations
AU2014236719B2 (en)	2013-03-15	2018-06-21	The California Institute For Biomedical Research	Compounds and methods for inducing chondrogenesis
US9573904B2 (en) *	2013-12-12	2017-02-21	Sumitomo Chemical Company, Limited	Aromatic compound and use thereof
CN104829536B (zh) *	2015-05-04	2017-12-29	陕西科技大学	一种具抗肿瘤活性的苯基吡唑羧酸类化合物及其合成方法
US10858314B2 (en) *	2015-05-27	2020-12-08	Kyorin Pharmaceutical Co., Ltd.	Urea derivative or pharmacologically acceptable salt thereof
CN109748873B (zh) *	2017-11-08	2021-02-02	北京嘉林药业股份有限公司	化合物及其治疗癌症的用途
EP3886854A4 (en)	2018-11-30	2022-07-06	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
WO2020124397A1 (en)	2018-12-19	2020-06-25	Inventisbio Shanghai Ltd.	C-terminal src kinase inhibitors
WO2020163689A1 (en)	2019-02-08	2020-08-13	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	20-hete formation inhibitors
AU2020417293A1 (en)	2020-01-03	2022-09-01	Berg Llc	Polycyclic amides as UBE2K modulators for treating cancer
EP3978487A1 (en) *	2020-09-30	2022-04-06	Origo Biopharma, S.L.	2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5
WO2022146698A1 (en) *	2020-12-29	2022-07-07	Revolution Medicines, Inc.	Sos1 inhibitors and uses thereof
WO2025231152A1 (en) *	2024-04-30	2025-11-06	The Cleveland Clinic Foundation	Compounds and methods for restoring beta-adrenergic receptor function

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996003385A1 (en) *	1994-07-21	1996-02-08	G.D. Searle & Co.	3,4-substituted pyrazoles for the treatment of inflammation
US5559137A (en) *	1994-05-16	1996-09-24	Smithkline Beecham Corp.	Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2753659B2 (ja) *	1990-09-03	1998-05-20	株式会社大塚製薬工場	ピラゾール誘導体
US5593992A (en) *	1993-07-16	1997-01-14	Smithkline Beecham Corporation	Compounds
JP3734180B2 (ja) *	1994-12-28	2006-01-11	エーザイ株式会社	新規ピラゾール誘導体

1998
- 1998-05-22 JP JP55065098A patent/JP2002508754A/ja not_active Withdrawn
- 1998-05-22 WO PCT/US1998/010436 patent/WO1998052940A1/en not_active Ceased
- 1998-05-22 SK SK1578-99A patent/SK157899A3/sk unknown
- 1998-05-22 ZA ZA984358A patent/ZA984358B/xx unknown
- 1998-05-22 AP APAP/P/1999/001715A patent/AP1246A/en active
- 1998-05-22 EE EEP199900527A patent/EE9900527A/xx unknown
- 1998-05-22 IL IL13299198A patent/IL132991A/xx not_active IP Right Cessation
- 1998-05-22 EP EP98923642A patent/EP1000055A1/en not_active Withdrawn
- 1998-05-22 EA EA199900953A patent/EA003925B1/ru not_active IP Right Cessation
- 1998-05-22 TR TR2000/00235T patent/TR200000235T2/xx unknown
- 1998-05-22 CA CA002291115A patent/CA2291115A1/en not_active Abandoned
- 1998-05-22 KR KR19997010820A patent/KR20010012854A/ko not_active Ceased
- 1998-05-22 HU HU0001880A patent/HUP0001880A3/hu unknown
- 1998-05-22 GE GEAP19985095A patent/GEP20033053B/en unknown
- 1998-05-22 NZ NZ501112A patent/NZ501112A/xx unknown
- 1998-05-22 PL PL98337020A patent/PL337020A1/xx unknown
- 1998-05-22 AU AU75883/98A patent/AU754830C/en not_active Ceased
- 1998-05-22 BR BR9809147-6A patent/BR9809147A/pt not_active Application Discontinuation
- 1998-05-22 CN CN98807369A patent/CN1264377A/zh active Pending
- 1998-05-22 ID IDW991425A patent/ID22982A/id unknown
1999
- 1999-11-19 NO NO995695A patent/NO995695L/no not_active Application Discontinuation
- 1999-11-19 IS IS5257A patent/IS5257A/is unknown
- 1999-11-22 OA OA9900252A patent/OA12981A/en unknown
- 1999-12-08 BG BG103964A patent/BG64313B1/bg unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5559137A (en) *	1994-05-16	1996-09-24	Smithkline Beecham Corp.	Compounds
WO1996003385A1 (en) *	1994-07-21	1996-02-08	G.D. Searle & Co.	3,4-substituted pyrazoles for the treatment of inflammation

Also Published As

Publication number	Publication date
NO995695D0 (no)	1999-11-19
KR20010012854A (ko)	2001-02-26
EA199900953A1 (ru)	2000-10-30
ID22982A (id)	1999-12-23
IS5257A (is)	1999-11-19
PL337020A1 (en)	2000-07-31
WO1998052940A1 (en)	1998-11-26
AP9901715A0 (en)	1999-12-31
TR200000235T2 (tr)	2000-05-22
BG103964A (en)	2000-08-31
NO995695L (no)	2000-01-21
SK157899A3 (en)	2000-08-14
AU754830B2 (en)	2002-11-28
AU7588398A (en)	1998-12-11
BG64313B1 (bg)	2004-09-30
CA2291115A1 (en)	1998-11-26
EE9900527A (et)	2000-06-15
IL132991A0 (en)	2001-03-19
HUP0001880A3 (en)	2002-03-28
OA12981A (en)	2006-10-13
JP2002508754A (ja)	2002-03-19
BR9809147A (pt)	2000-08-01
ZA984358B (en)	1999-05-24
GEP20033053B (en)	2003-08-25
EP1000055A1 (en)	2000-05-17
HUP0001880A2 (en)	2001-03-28
NZ501112A (en)	2002-10-25
EA003925B1 (ru)	2003-10-30
CN1264377A (zh)	2000-08-23
AU754830C (en)	2004-02-12
IL132991A (en)	2005-11-20

Publication	Publication Date	Title
AP2001002172A0 (en)	2001-06-30	Substituted pyrazoles as p38 kinase inhibitors
TR200000235T2 (tr)	2000-05-22	p38 kinaz inhibitörleri olarak ikame edilmiş pirazoller.
BR9809451A (pt)	2000-06-20	Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38.
MY119800A (en)	2005-07-29	Pyridine derivatives
AU3328499A (en)	1999-10-11	Phthalazinone pde iii/iv inhibitors
MY133392A (en)	2007-11-30	Novel substituted pyrazole derivatives
NO942618L (no)	1994-08-30	Imidazolderivater og deres anvendelse som cytokin-inhibitorer
PL327735A1 (en)	1998-12-21	Novel substituted derivatives of imidazole
MXPA02011977A (es)	2003-04-22	Herbicidas de piridina sustituidas.
IL107947A0 (en)	1994-04-12	Substituted pyrazoles
MY128485A (en)	2007-02-28	Pesticidal 1-arylpyrazoles
DE60023025D1 (de)	2006-02-16	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
AU1783201A (en)	2001-06-04	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
GB0308201D0 (en)	2003-05-14	Novel compounds
ATE291018T1 (de)	2005-04-15	Pyrazol verbindungen und ihre verwendung
PT920426E (pt)	2004-02-27	Novos derivados de tiazole com efeito inibidor de fosfodiesterase
AU2001263278A1 (en)	2002-01-08	Cyclic gmp-specific phosphodiesterase inhibitors
AU1781601A (en)	2001-06-04	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
MX9702203A (es)	1997-06-28	Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
DE60036558D1 (de)	2007-11-08	Phthalazinon-derivate als pde 4 hemmer
AU2001296699A1 (en)	2002-05-21	Condensed pyrazindione derivatives as pde inhibitors
MXPA03000887A (es)	2004-04-05	Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.
MY141481A (en)	2010-04-30	Substituted pyrazoles as p38 kinase inhibitors
IL141009A0 (en)	2002-02-10	N-substituted azabicycloheptane derivatives, production and use thereof
SI0937075T1 (en)	2004-06-30	New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.